Alpha-Beta Gliadin IgG

If you feel worse after eating bread or pasta but your standard celiac blood work came back normal, this marker gives you one more angle to look at. It checks whether your immune system has produced antibodies against gliadin, one of the proteins in wheat gluten.

A positive result tells you your body is reacting to gluten in some way. It does not, by itself, tell you whether that reaction is celiac disease, a milder gluten sensitivity, or an immune blip with no clear health consequence.

What This Antibody Actually Is

Alpha-beta gliadin IgG (an immunoglobulin G antibody, meaning one of the main defensive proteins your immune system produces, aimed at the alpha and beta gliadin proteins in wheat) is made by immune cells after you eat gluten. It is a circulating antibody your own body builds in response to a food protein.

The test measures the amount of this antibody in your blood. A high level reflects that immune cells in your gut have recognized gliadin and switched on antibody production. Because commercial gliadin used in these tests contains a mix of gluten proteins, a positive result usually reflects binding to several related wheat proteins rather than one pure molecule.

A Nonspecific Signal, Not a Diagnosis

Here is the part that trips people up. This is not a clean "you have it or you don't" test. Anti-gliadin IgG turns up in people with celiac disease, in people with milder gluten sensitivity, and in a meaningful number of healthy people and people with unrelated conditions. Reading a lone positive as proof of celiac disease is the single most common mistake made with this marker.

The way to hold both facts at once is this: the antibody marks immune contact with gluten, not a specific disease. Whether that contact matters depends on your symptoms, your other celiac antibodies, and sometimes a biopsy. Think of it as a lead to follow, not a verdict.

Celiac Disease

For celiac disease, native anti-gliadin IgG is the weakest of the gluten-related blood tests. Its sensitivity varies widely from study to study, reported anywhere from about 25 to over 90 out of 100 people who truly have celiac disease, so it misses a meaningful share of cases and cannot be relied on as a screen. A positive result also means very different things depending on who is tested: in symptomatic people referred for biopsy it more often reflects real disease, while in people without symptoms it frequently does not.

This is why more specific tests have replaced native gliadin IgG in the celiac workup, and current guidelines from major gastroenterology societies no longer recommend it for diagnosis. The tissue transglutaminase IgA test (tTG-IgA, an antibody against one of your own enzymes that gluten activates) and the deamidated gliadin peptide tests (DGP, which target a chemically altered form of gliadin) are more accurate for celiac disease. In pooled data, DGP IgG testing reached about 88 out of 100 cases caught with high specificity, still slightly behind tissue transglutaminase testing. Native gliadin IgG, the antibody this test measures, sits below both.

What this means for you: a positive native gliadin IgG in the setting of gut symptoms is a reason to pursue the more specific celiac antibodies, not a reason to conclude anything on its own.

Non-Celiac Gluten Sensitivity

Some people react to gluten with real symptoms but do not have celiac disease or a wheat allergy, a pattern often called non-celiac gluten sensitivity. Anti-gliadin IgG is one of the few blood signals that shows up in this group, detected in about a quarter of people in one survey of those being evaluated for it, though reported rates vary widely across studies.

That said, no blood test has been validated to confirm non-celiac gluten sensitivity, and anti-gliadin IgG is not an exception. A positive here is consistent with gluten reactivity, but the diagnosis still rests on symptoms, ruling out celiac disease and wheat allergy, and how you respond to removing and reintroducing gluten.

Where Else It Shows Up

Elevated anti-gliadin IgG has been reported across a scatter of conditions unrelated to the gut lining. Raised levels appeared in 41 of 99 people with sarcoidosis, in children with autism (especially those with digestive symptoms), and in about 30% of people with schizophrenia compared with roughly 20% of comparison participants. It has also been found more often in people with bipolar disorder.

These associations are real but heterogeneous, and in most cases the celiac-specific antibodies stay negative. In studies of nerve and balance disorders, low-level positivity carried uncertain meaning and may simply reflect gut inflammation rather than a gluten-driven disease. The honest read is that a positive result can accompany these conditions, but its role in causing them is unproven.

Why One Reading Is Worth More Than a Snapshot

This antibody responds to what you eat, which makes tracking it over time more informative than any single value. When gluten leaves the diet, the immune trigger disappears and native anti-gliadin IgG tends to fall over the following months, often to undetectable levels within roughly 3 to 9 months. A downward trend after cutting gluten suggests the earlier signal was genuinely gluten-driven.

A practical approach: get a baseline while you are still eating gluten normally, and if you make dietary changes, recheck in 3 to 6 months to see whether the number moves. If you are using this marker to explore a gluten connection, your own before-and-after data is far more useful than one reading compared against a lab's reference range, especially since this is an older test that current guidelines no longer include in the celiac workup and that has no settled cutpoints.

When Results Can Be Misleading

• Already off gluten: if you have been avoiding gluten before the test, this antibody may be low or undetectable even if you have an underlying gluten-related condition. A normal result while gluten-free does not rule anything out. For serologic testing to be interpretable, guidelines suggest eating a meaningful amount of gluten, on the order of two slices of bread a day, for at least several weeks beforehand.
• Nonspecific positives: in healthy blood donors, isolated native gliadin IgG had essentially no predictive value for celiac disease. A positive in someone without symptoms often means very little.
• Which assay was run: older native gliadin tests and newer deamidated gliadin peptide tests are not interchangeable, and results can vary between labs. Make sure you know which one your result reflects.
• Lab factors: as with any antibody immunoassay, occasional technical interference can shift a single reading, which is another reason to confirm an unexpected result rather than act on it once.

What to Do With an Unexpected Result

A positive result is a starting point for a short workup, not an endpoint. The most useful next step is to pair it with the more specific celiac serologies: tissue transglutaminase IgA plus a total IgA level (to make sure you are not IgA deficient, which can hide celiac disease), and often deamidated gliadin peptide IgG and IgA. If those are positive, a gastroenterologist can advise on whether a biopsy confirms celiac disease.

If the celiac antibodies are negative but gluten symptoms persist, the conversation shifts toward non-celiac gluten sensitivity or wheat allergy, which are evaluated differently. Do all of this while still eating gluten, because going gluten-free first can erase the very antibodies the tests rely on. The combination of findings, not this one number, is what should guide your decision.